Measuring and Improving Coproduction Using coopeRATE
NCT04060329 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 280
Last updated 2020-07-09
Summary
The purpose of this study is to identify new methods of measuring and improving collaborative goal setting between patients and clinicians in adult cystic fibrosis care.
Conditions
Interventions
- BEHAVIORAL
-
coopeRATE Prompt
The coopeRATE Prompt intervention is a set of two questions delivered to patients immediately before the clinical encounter that elicit their concerns and goals.
Sponsors & Collaborators
-
Cystic Fibrosis Foundation
collaborator OTHER - collaborator OTHER
-
Dartmouth-Hitchcock Medical Center
lead OTHER
Principal Investigators
-
Glyn Elwyn · Dartmouth College
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-12-02
- Primary Completion
- 2020-03-16
- Completion
- 2020-03-16
Countries
- United States
Study Locations
More Related Trials
-
Surrogate Markers of Response to New Therapies in Cystic Fibrosis Patients
NCT02965326 ·Status: RECRUITING ·Phase: NA
-
Airway Secretion Clearance in Cystic Fibrosis
NCT00839644 ·Status: TERMINATED ·Phase: NA
-
Transfer Impedance in Cystic Fibrosis
NCT00743158 ·Status: WITHDRAWN
-
Modulate-CF: Cystic Fibrosis Transmembrane Regulator (CFTR) Biomarker Study to Evaluate the Rescue of Mutant CFTR in Patients With Cystic Fibrosis Treated With CFTR-modulators
NCT04732910 ·Status: RECRUITING
-
A Study of Females With CF Throughout Pregnancy and Post-partum, and Follow up of Their Offspring
NCT06797206 ·Status: RECRUITING
-
Web-based Delivery of Effective Treatment for Growth in Cystic Fibrosis
NCT01686672 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of CFTR Modulators According to Co-therapy
NCT05663255 ·Status: UNKNOWN
-
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
NCT04568980 ·Status: COMPLETED
-
Observational Trial of the Longitudinal Effects of CFTR Modulator Drugs
NCT04353752 ·Status: COMPLETED
-
Absorptive Clearance in the Cystic Fibrosis Airway
NCT00541190 ·Status: COMPLETED ·Phase: NA
-
Study of Metabolic Effects of Pregnancy in Women With Cystic Fibrosis
NCT00014768 ·Status: TERMINATED
-
Cystic Fibrosis (CF) Flow Rates Study
NCT00779077 ·Status: COMPLETED
-
LC-MS/MS Based Method Development for the Monitoring of Antibiotic Concentrations in Sputum of Cystic Fibrosis Patients
NCT02840136 ·Status: TERMINATED ·Phase: NA
-
Safety and Efficacy of Recombinant Adeno-Associated Virus Containing the CFTR Gene in the Treatment of Cystic Fibrosis
NCT00073463 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
MyVoice:CF Decision Aid for Women With Cystic Fibrosis
NCT04825236 ·Status: COMPLETED ·Phase: NA
-
Cystic Fibrosis (CF) Leukocyte Genes as Biomarkers for Novel Therapies
NCT00727285 ·Status: COMPLETED
-
COVID-19 Antibody Responses in Cystic Fibrosis
NCT04992234 ·Status: COMPLETED
-
A Novel Assay to Quantify Treatment Response in Cystic Fibrosis (CF)
NCT01626157 ·Status: COMPLETED
-
Electrical Impedance Imaging of Patients With Cystic Fibrosis
NCT02524704 ·Status: COMPLETED
-
Impact of Discontinuing Dornase Alfa in People With CF on Highly Effective CFTR Modulator Therapy-A SIMPLIFY Sub-Study
NCT06350474 ·Status: COMPLETED ·Phase: NA
-
Sensor Augmented Pump (SAP) Therapy for Inpatient CFRD Management
NCT03939065 ·Status: TERMINATED ·Phase: NA
-
COVID-19 Antibody Responses In Cystic Fibrosis
NCT06274840 ·Status: RECRUITING
-
MENstrual Symptom Tracking to Understand and Assess (Women) Living With Cystic Fibrosis
NCT04620096 ·Status: COMPLETED
-
COVID-19 Antibody Responses In Cystic Fibrosis
NCT05074680 ·Status: ACTIVE_NOT_RECRUITING
-
Sweat Evaporimeter Measurement
NCT01708655 ·Status: COMPLETED ·Phase: NA